US5128247A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources
Assignee: The University of Texas System
•
Filing: 1989-08-14
•
Granted: 1992-07-07
•
Expires: 2009-08-14
Abstract
Abstract The present invention relates to methods and compositons for isolation of nucleic acids from cells. In particular aspects, this invention relates to the use of chaotropic compositions, such as guanidine hydrochloride or guanidinium isothiocyanate, in combination with polyanionic compositions, such as those containing sulfated polysaccharides (i.e., heparin or heparitin sulfate), for the isolation of nucleic acids (RNA or DNA). This method involves disrupting and lysing cells using a nucleic acid releasing composition containing a chaotropic component for the release of nucleic acids from the cell (guanidine hydrochloride or guanidinium isothiocyanate). The released nucleic acids are collected by ethanol precipitation and resuspended before exposure to a polyanion-containing protein dissociating composition which promotes the dissociation of nucleic acid associated proteins from the resuspended nucleic acids. The isolated nucleic acids are washed, further collected by ethanol precipitation and resuspended in a selective buffer prior to further use.
Inventors
- 👤 Charles A. Koller
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 13:58
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1003; Y; Y10; Y10S; Y10S435/00; Y10S435/82
Claims Analysis
Total Claims: 35
Claim 1
Independent Claim
101 words
An efficient method for obtaining substantially intact, essentially protein-free nucleic acids from cells comprising the steps of: a) disrupting and lysing cells using a nucleic acid releasing composition having a chaotropic component to release the nucleic acids from the cells; b) precipitating the released nucleic acids from the lysed cells; c) resuspending the precipitated nucleic acids; and d) subjecting the resuspended nucleic acids to a polyanionic sulfated polysacchanide protein dissociating composition at a level effective to promote the dissociation of nucleic acid-associated proteins from the resuspended nucleic acids to obtain substantially intact nucleic acids free of strong interactions with contaminating proteins.
Claim 2
Dependent Claim
101 words
An efficient method for obtaining substantially intact, essentially protein-free nucleic acids from cells comprising the steps of: a) disrupting and lysing cells using a nucleic acid releasing composition having a chaotropic component to release the nucleic acids from the cells; b) precipitating the released nucleic acids from the lysed cells; c) resuspending the precipitated nucleic acids; and d) subjecting the resuspended nucleic acids to a polyanionic sulfated polysacchanide protein dissociating composition at a level effective to promote the dissociation of nucleic acid-associated proteins from the resuspended nucleic acids to obtain substantially intact nucleic acids free of strong interactions with contaminating proteins.
Claim 3
Dependent Claim
12 words
The method of claim 1, further comprising collecting the precipitated nucleic acids.
Claim 4
Dependent Claim
21 words
The method of claim 2, wherein collecting the precipitated nucleic acids comprises centrifuging the precipitated nucleic acids to form a pellet.
Claim 5
Dependent Claim
21 words
The method of claim 1, further comprising subjecting the dissociating composition-treated nucleic acids to digestion with a protease to digest proteins.
Claim 6
Dependent Claim
23 words
The method of claim 1, further comprising subjecting the dissociating composition-treated nucleic acids to digestion with an essentially DNAse-free RNAse to digest RNA.
Claim 7
Dependent Claim
20 words
The method of claim 1, further comprising subjecting the dissociated nucleic acids to digestion with a DNAse to digest DNA.
Claim 8
Dependent Claim
23 words
The method of claim 1, further comprising subjecting the dissociated nucleic acids to a concentration of ethanol effective to precipitate the nucleic acids.
Claim 9
Dependent Claim
22 words
The method of claim 1, further comprising washing the dissociated nucleic acids and placing the washed nucleic acids into a selected buffer.
Claim 10
Dependent Claim
12 words
The method of claim 1, wherein the isolated nucleic acid comprises DNA.
Claim 11
Dependent Claim
12 words
The method of claim 1, wherein the isolated nucleic acid comprises RNA.
Claim 12
Dependent Claim
19 words
The method of claim 1, wherein the cells are obtained from blood components or solid tumor tissue biopsy samples.
Claim 13
Dependent Claim
21 words
The method of claim 1, wherein the chaotropic component of the nucleic acid releasing composition comprises guanidine hydrochloride or guanidinium isothiocyanate.
Claim 14
Dependent Claim
12 words
The method of claim 12, wherein the chaotropic component comprises guanidine hydrochloride.
Claim 15
Dependent Claim
12 words
The method of claim 12, wherein the chaotropic component comprises guanidinium isothiocyanate.
Claim 16
Dependent Claim
15 words
The method of claim 1, wherein the nucleic acid releasing composition further includes a detergent.
Claim 17
Dependent Claim
16 words
The method of claim 15, wherein the detergent comprises a surface-active agent of the anionic type.
Claim 18
Dependent Claim
14 words
The method of claim 16, wherein the anionic surface-active detergent comprises sodium dodecyl sulfate.
Claim 19
Dependent Claim
12 words
The method of claim 16, wherein the anionic surface-active detergent comprises sarcosyl.
Claim 20
Dependent Claim
17 words
The method of claim 1, wherein the nucleic acid releasing composition further includes a sulfhydryl reducing agent.
Claim 21
Dependent Claim
14 words
The method of claim 19, wherein the sulfhydryl reducing agent comprises 2-mercaptoethanol or DTT.
Claim 22
Dependent Claim
28 words
The method of claim 1, wherein the nucleic acid releasing composition which further includes a level of salt effective to promote dissociation of proteins from the nucleic acids.
Claim 23
Dependent Claim
31 words
The method of claim 21, wherein the level of salt effective to promote dissociation of proteins from the nucleic acids comprises salt in a concentration ranging from about 0.1M to 0.9M.
Claim 24
Dependent Claim
22 words
The method of claim 22, wherein the level of salt further includes salt in a concentration ranging from about 0.4M to 0.6M.
Claim 25
Dependent Claim
18 words
The method of claim 21, wherein the salt comprises sodium chloride, sodium acetate, potassium acetate or ammonium acetate.
Claim 26
Dependent Claim
25 words
The method of claim 1, wherein the polyanion-containing protein-dissociating composition comprises a sulfated polysaccharide in a concentration ranging from about 100 micrograms to 1500 micrograms/ml.
Claim 27
Dependent Claim
25 words
The method of claim 25, wherein the level of sulfated polysaccharide comprises sulfated polysaccharide in a concentration ranging from about 200 micrograms to 800 micrograms/ml.
Claim 28
Dependent Claim
14 words
The method of claim 25, wherein the sulfated polysaccharide comprises heparin or heparitin sulfate.
Claim 29
Dependent Claim
11 words
The method of claim 25, wherein the sulfated polysaccharide comprises heparin.
Claim 30
Dependent Claim
12 words
The method of claim 25, wherein the sulfated polysaccharide comprises heparitin sulfate.
Claim 31
Dependent Claim
12 words
The method of claim 28, wherein the sulfated polysaccharide comprises sodium heparin.
Claim 32
Dependent Claim
12 words
The method of claim 28, wherein the sulfated polysaccharide comprises lithium heparin.
Claim 33
Dependent Claim
23 words
The method of claim 25, wherein the polyanion-containing component further includes phosphate in a concentration ranging from about 0.1 mM to 25 mM.
Claim 34
Independent Claim
170 words
A method for isolating nucleic acids from cells, comprising the steps of: a) disrupting and lysing the cells, thereby releasing nucleic acids which are complexed to proteins, using a composition containing guanidine hydrochloride or guanidinium isothiocyanate, at a concentration ranging from about 3M to 8M, and said composition furthers contains sodium acetate or sodium chloride at a concentration ranging from 0.01M to 0.6M b) precipitating the released nucleic acids from the lysed cells; c) resuspending the precipitated nucleic acids in a selected buffer; d) dissociating the proteins from the resuspended nucleic acids using a composition containing a sulfated polysaccharide comprised of either heparin or heparitin sulfate at a concentration ranging from about 0.1 milligrams to about 1.0 milligram per milliliter and said composition further contains phosphate in a concentration ranging from about 0.1 mM to about 25 mM; and f) collecting the isolated and partially purified nucleic acids wherein collecting comprises centrifuging the nucleic acids to form a pellet and dissolving the pellet in a selective buffer for further processing.
Claim 35
Independent Claim
170 words
A method for isolating nucleic acids from cells, comprising the steps of: a) disrupting and lysing the cells, thereby releasing nucleic acids which are complexed to proteins, using a composition containing guanidine hydrochloride or guanidinium isothiocyanate, at a concentration ranging from about 3M to 8M, and said composition furthers contains sodium acetate or sodium chloride at a concentration ranging from 0.01M to 0.6M b) precipitating the released nucleic acids from the lysed cells; c) resuspending the precipitated nucleic acids in a selected buffer; d) dissociating the proteins from the resuspended nucleic acids using a composition containing a sulfated polysaccharide comprised of either heparin or heparitin sulfate at a concentration ranging from about 0.1 milligrams to about 1.0 milligram per milliliter and said composition further contains phosphate in a concentration ranging from about 0.1 mM to about 25 mM; and f) collecting the isolated and partially purified nucleic acids wherein collecting comprises centrifuging the nucleic acids to form a pellet and dissolving the pellet in a selective buffer for further processing.
References Cited (Backward Citations)
US4407957A
Cited
US4830969A
Cited
US4508826A
Cited
EP0127327A1
Cited
US4828990A
Cited
EP0215533A2
Cited
US4935342A
Cited
US4968432A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-07-07 | 1996-01-06 | 1996-07-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-07-07 | 2000-01-06 | 2000-07-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-07-07 | 2004-01-06 | 2004-07-07 | $7700.00 | Window Closed / Lapsed |